Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

Lignende værker

• Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease
  af: Balakrishnan, Vijayakumar, et al.
  Udgivet: (2020)
• Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
  af: Valentina L. Kouznetsova, et al.
  Udgivet: (2020-09-01)
• Repurposing of FDA-approved drugs against cancer – focus on metastasis
  af: Ozsvári, Béla, et al.
  Udgivet: (2016)
• In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors
  af: Gurung, Arun Bahadur, et al.
  Udgivet: (2020)
• Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs
  af: Kouznetsova, Valentina L., et al.
  Udgivet: (2020)